Skip to main content
Loading

Ensuring Biosafety in Next-Generation Immunotherapies: Strategies and Challenges

17 Jun 2025
Clinical Development
  • Best practices for biosafety assessment in immunotherapies.
  • Regulatory considerations for biosafety in immunotherapeutic product development.
  • Risk mitigation strategies during manufacturing and clinical application.
Industry Expert
Joe Newcome, Senior Director - Minaris Advanced Therapies

Minaris Advanced Therapies